Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
about
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsSurgical treatment of drug-resistant tuberculosisMultidrug-resistant tuberculosis in Ethiopia: efforts to expand diagnostic services, treatment and careStructure, dynamics, and interaction of Mycobacterium tuberculosis (Mtb) DprE1 and DprE2 examined by molecular modeling, simulation, and electrostatic studiesSlow elimination of multidrug-resistant tuberculosisHigh prevalence and low cure rate of tuberculosis among patients with HIV in Xinjiang, ChinaAmbulatory-based standardized therapy for multi-drug resistant tuberculosis: experience from Nepal, 2005-2006Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in SwedenRates of anti-tuberculosis drug resistance in Kampala-Uganda are low and not associated with HIV infectionSocial, clinical and microbiological differential characteristics of tuberculosis among immigrants in SpainCharacteristics and treatment outcomes of patients with MDR and XDR tuberculosis in a TB referral hospital in Beijing: a 13-year experienceDirect nitrate reductase assay versus microscopic observation drug susceptibility test for rapid detection of MDR-TB in UgandaTransmission pattern of drug-resistant tuberculosis and its implication for tuberculosis control in eastern rural ChinaPrevalence of drug-resistant tuberculosis in mainland China: systematic review and meta-analysisSurvival of civilian and prisoner drug-sensitive, multi- and extensive drug- resistant tuberculosis cohorts prospectively followed in RussiaA molecular epidemiological and genetic diversity study of tuberculosis in Ibadan, Nnewi and Abuja, NigeriaMultidrug-resistant and extensively drug-resistant tuberculosis in multi-ethnic region, Xinjiang Uygur Autonomous Region, ChinaMicroscopic-observation drug-susceptibility assay for the diagnosis of drug-resistant tuberculosis in Harare, ZimbabweControl of (multi)drug resistance and tuberculosis incidence over 23 years in the context of a well-supported tuberculosis programme in rural MalawiAnti-tuberculosis drug resistance among new and previously treated sputum smear-positive tuberculosis patients in Uganda: results of the first national surveyAssociation between HIV/AIDS and multi-drug resistance tuberculosis: a systematic review and meta-analysisThe burden of MDR/XDR tuberculosis in coastal plains population of ChinaMulti drug and other forms of drug resistant tuberculosis are uncommon among treatment naïve tuberculosis patients in TanzaniaRisk Factors for Multidrug-Resistant Tuberculosis among Patients with Pulmonary Tuberculosis at the Central Chest Institute of ThailandIdentification of New Molecular Entities (NMEs) as Potential Leads against Tuberculosis from Open Source Compound RepositoryDiscordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence CountryPrevalence of Drug Resistance Mycobacterium Tuberculosis among Patients Seen in Coast Provincial General Hospital, Mombasa, KenyaPerfusing chemotherapy by percutaneous lung puncture in the treatment of extensive drug resistant pulmonary tuberculosisFeasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation studyEfficacy and safety of a four-drug fixed-dose combination regimen versus separate drugs for treatment of pulmonary tuberculosis: a systematic review and meta-analysis.World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update.Blood cultures for the diagnosis of multidrug-resistant and extensively drug-resistant tuberculosis among HIV-infected patients from rural South Africa: a cross-sectional study.Multidrug-resistant TB in Zambia: review of national data from 2000 to 2011.High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India.Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis.Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South VietnamEstimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation studyRe-thinking global health sector efforts for HIV and tuberculosis epidemic control: promoting integration of programme activities within a strengthened health system.Clinical prediction rule for stratifying risk of pulmonary multidrug-resistant tuberculosis.
P2860
Q24200879-461A52B1-8697-4E90-8FA2-EEAADC33B4A6Q24201466-81B91739-2581-4F81-ACCB-890788BEAC9EQ26999739-B06A67F6-93EE-4715-955F-F1B5B3729F5EQ27005623-CFF80036-3638-467A-8680-D0D3CDD7FCB8Q27311652-4568DA52-1D36-4E35-98D2-AD88768E929CQ28278696-9256A3E7-1BF2-4127-A6E3-145AFED4B01DQ28365052-FE3C7F5E-6C76-4726-BF46-004F29293085Q28472337-7FC356DA-095B-4463-90F0-D89678B7D905Q28474118-50B2C350-0563-4517-8C06-1C35AF2859C1Q28476713-14B48440-6FEC-48A8-8E0E-E1B6CC00133EQ28476792-B98F44B3-02D8-44DD-B1B4-E800461DBDFCQ28478005-38D447BD-4B05-4EFD-A22F-B549E3B3BFD4Q28478104-B4C422A3-5825-4D4A-B185-D1CF852E0FE7Q28478125-B2A4EB86-FE4F-407D-BC37-77BBACF0D719Q28478421-5D09FCDE-FF31-4A70-813A-656C1E5015AAQ28478528-CCBBD802-0FF0-4262-9C5D-DA06D81022D3Q28480484-8E44A807-8AA2-48A3-A298-D6A85ED3536AQ28481175-88940F20-F435-457B-A3A9-A0A278EA1670Q28486123-EA38A742-1684-413C-A6EB-5FC5CC51021EQ28487692-75550D17-8775-4D8A-A3B4-7ACE173DAC90Q28535035-685FDEBB-55B7-43B0-A2A2-D3949BBF4642Q28538427-418B03CB-4E06-41B2-A082-2736FDBA3CE9Q28543426-59FCD487-33E2-45C4-9CE3-493CE55CB407Q28545802-6AEFE1AC-60AC-4A78-BD98-347DA2ABC58EQ28550093-03CC5C10-2CF8-4D1C-98B1-592E6F0B2A2AQ28551394-9FA7DD22-0E53-4B74-A9F1-9C7E975F24B9Q28551469-6791EF81-D7BA-482A-B18F-85B95A496EDFQ28554564-3309C9E2-455D-4931-B15D-22F55E13FF44Q28710520-846E9EBD-D43C-4A6B-98E4-219FD3BE750FQ29615717-0484444D-1E44-4BED-8929-93F71BEA93FAQ30239768-891653E6-5C07-4635-8489-3D7F0E6FD6A7Q30377488-DFA859E8-1721-4C98-8E21-1673041412D4Q30433540-C74CBB31-80BD-4EB6-87E9-EF9665FBE0E6Q30666715-B9950185-A510-40E0-B1DC-FF4CB474D012Q33475938-C06C9BD5-36AB-44B4-BB2E-3FD019838E06Q33561777-099C5F7C-5F14-41AA-9CF1-CD10ACC489E0Q33595062-1F1BA79A-A73D-4988-9F9A-247ADC1CA85EQ33611442-0ED291E3-19CD-4DD5-A2FD-84BE260198E3Q33625404-651549B4-1A7B-4627-B2E5-04252EAE6494Q33658873-14263256-6497-40B4-9829-316FAF3B4D21
P2860
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epidemiology of antituberculos ...... Drug Resistance Surveillance.
@en
Epidemiology of antituberculos ...... Drug Resistance Surveillance.
@nl
type
label
Epidemiology of antituberculos ...... Drug Resistance Surveillance.
@en
Epidemiology of antituberculos ...... Drug Resistance Surveillance.
@nl
prefLabel
Epidemiology of antituberculos ...... Drug Resistance Surveillance.
@en
Epidemiology of antituberculos ...... Drug Resistance Surveillance.
@nl
P2093
P1433
P1476
Epidemiology of antituberculos ...... Drug Resistance Surveillance.
@en
P2093
Abigail Wright
Armand Van Deun
C N Paramasivan
Dennis Falzon
Fadila Boulabhal
Francis Drobniewski
Global Project on Anti-Tuberculosis Drug Resistance Surveillance
Kai Man Kam
Knut Feldman
Lucia Barrera
P304
P356
10.1016/S0140-6736(09)60331-7
P407
P577
2009-04-15T00:00:00Z